These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22952286)

  • 1. Chronic aspirin and statin therapy in patients with impaired renal function and acute coronary syndromes: results from the IN-ACS Outcome Registry.
    Sciahbasi A; Rizzello V; Gonzini L; Giampaoli S; Greco C; Di Pasquale G; Mureddu GF; Di Chiara A; Lioy E; Boccanelli A
    Eur J Prev Cardiol; 2014 Feb; 21(2):214-21. PubMed ID: 22952286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.
    Carrero JJ; Varenhorst C; Jensevik K; Szummer K; Lagerqvist B; Evans M; Spaak J; Held C; James S; Jernberg T
    Kidney Int; 2017 Jan; 91(1):216-226. PubMed ID: 27865441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
    Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
    Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
    Elbarouni B; Banihashemi SB; Yan RT; Welsh RC; Kornder JM; Wong GC; Anderson FA; Spencer FA; Grondin FR; Goodman SG; Yan AT;
    Am J Cardiol; 2012 May; 109(10):1418-24. PubMed ID: 22381155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chronic aspirin and statin therapy on presentation of patients with acute myocardial infarction and impaired renal function.
    Sciahbasi A; Arcieri R; Quarto M; Pendenza G; Lanzillo C; Summaria F; Romagnoli E; Commisso C; Penco M; Lioy E
    Prev Cardiol; 2010; 13(1):18-22. PubMed ID: 20021622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
    Amad H; Yan AT; Yan RT; Huynh T; Gore JM; Montalescot G; DeYoung JP; Gallo R; Rose B; Steg PG; Goodman SG;
    Can J Cardiol; 2012; 28(1):48-53. PubMed ID: 22112683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U; Jünger C; Zahn R; Bauer T; Bestehorn K; Senges J; Gitt A
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
    Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
    Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Natsuaki M; Furukawa Y; Morimoto T; Sakata R; Kimura T;
    Am J Cardiol; 2012 Dec; 110(11):1568-77. PubMed ID: 22935527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome.
    Qadir MI; Rehman A; HamidAkash MS; Irfan M; Baber M; Hussain SB
    Pak J Pharm Sci; 2016 Nov; 29(6):2103-2104. PubMed ID: 28375131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score.
    Dudek D; Chyrchel B; Siudak Z; Depukat R; Chyrchel M; Dziewierz A; Mielecki W; Rakowski T; Rzeszutko Ł; Dubiel J
    Kardiol Pol; 2008 Jan; 66(1):28-34; discussion 35-6. PubMed ID: 18266185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
    Dziewierz A; Siudak Z; Rakowski T; Zdzienicka J; Dykla D; Mielecki W; Dubiel JS; Dudek D
    Cardiol J; 2008; 15(5):451-7. PubMed ID: 18810721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients.
    Suzuki H; Watanabe Y; Kumagai H; Shuto H
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):306-15. PubMed ID: 24280596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
    Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes.
    Cuculi F; Radovanovic D; Eberli FR; Stauffer JC; Bertel O; Erne P;
    Cardiology; 2008; 109(3):156-62. PubMed ID: 17726316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.
    El-Menyar A; AlHabib KF; Al-Motarreb A; Hersi A; Al Faleh H; Asaad N; Al Saif S; Almahmeed W; Sulaiman K; Amin H; Al-Lawati J; Alsheikh-Ali AA; AlQahtani A; Al-Sagheer NQ; Singh R; Al Suwaidi J
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):127-35. PubMed ID: 22257172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.
    Klempfner R; Goldenberg I; Fisman EZ; Matetzky S; Amit U; Shemesh J; Tenenbaum A
    Am J Cardiol; 2014 Jan; 113(1):12-6. PubMed ID: 24157192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very early initiation of statin therapy and mortality in patients with acute coronary syndrome.
    Angeli F; Reboldi G; Garofoli M; Ramundo E; Verdecchia P
    Acute Card Care; 2012 Mar; 14(1):34-9. PubMed ID: 22295883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.